Literature DB >> 32317119

Concise Review of the Clinical Approach to the Exclusion and Diagnosis of Pulmonary Embolism in 2020.

Evan Mitchell Tomkiewicz, Jeffery Allen Kline.   

Abstract

Pulmonary embolism has extremely varied clinical presentations and can be difficult to diagnose. Clinical decision rules can help determine the probability of pulmonary embolism by assessment of the clinical presentation. After the diagnosis, several prognostic rules can be used to risk-stratify and facilitate outpatient treatment of pulmonary embolism. This review addresses the utility of clinical decision rules, biomarkers in the diagnosis of pulmonary emoblism, high-risk patient phenotypes, the use of this data to make disposition decisions for patients with a diagnosis of PE, and recent shifts in the management of pulmonary embolism in the clinical setting.
Copyright © 2020 Emergency Nurses Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers in pulmonary embolism; Clinical decision rules; Contribution to emergency nursing practice; Pulmonary embolism

Year:  2020        PMID: 32317119     DOI: 10.1016/j.jen.2020.02.018

Source DB:  PubMed          Journal:  J Emerg Nurs        ISSN: 0099-1767            Impact factor:   1.836


  3 in total

1.  Construction of Pulmonary Embolism Prediction, Early Warning, and Precontrol MDT Collaborative Nursing Model Based on the Smith Model.

Authors:  Qian Lv; Yue Liu; Na Zhang; Haini Qi; Xiang Li; Rui Zhang; Bing Sun; Yifang Zhu
Journal:  Comput Math Methods Med       Date:  2022-08-05       Impact factor: 2.809

2.  Ozone Alerts and Respiratory Emergencies: The Environmental Protection Agency's Potential Biological Pathways for Respiratory Effects.

Authors:  Jessica Castner
Journal:  J Emerg Nurs       Date:  2020-07       Impact factor: 1.836

3.  Expression and diagnostic value of circulating miRNA-190 and miRNA-197 in patients with pulmonary thromboembolism.

Authors:  XiaoTing Zhou; QiaoZhen Wu; TianBo Hao; Rui Xu; XiaoYun Hu; LingYun Dong
Journal:  J Clin Lab Anal       Date:  2020-09-12       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.